SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-127833
Filing Date
2018-04-24
Accepted
2018-04-24 09:00:32
Documents
3
Period of Report
2018-04-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d569876d8k.htm 8-K 16275
2 EX-99.1 d569876dex991.htm EX-99.1 5100
3 GRAPHIC g569876g0424005934663.jpg GRAPHIC 1892
  Complete submission text file 0001193125-18-127833.txt   25567
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 18770282
SIC: 2834 Pharmaceutical Preparations